This inventor holds 8 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Perseid Therapeutics LLC. Active years: 2010-2013.
Location History:
- Fremont, CA (US) (2012)
- San Francisco, CA (US) (2010 - 2013)
Company Filing History:
Years Active: 2010-2013
Title: The Innovative Contributions of Steven J Chapin
Introduction
Steven J Chapin is a notable inventor based in San Francisco, CA, with a significant portfolio of eight patents. His work primarily focuses on immunosuppressive polypeptides and nucleic acids, contributing to advancements in medical science.
Latest Patents
Chapin's latest patents include innovations related to immunosuppressive polypeptides and nucleic acids encoding such polypeptides. One of the key aspects of his inventions involves mutant CTLA-4 polypeptides and the nucleic acids that encode them. These inventions provide compositions and methods for utilizing these polypeptides and nucleic acids, showcasing his commitment to enhancing therapeutic options.
Career Highlights
Throughout his career, Chapin has worked with prominent companies such as Perseid Therapeutics LLC and Astellas Pharma GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to impactful contributions in the field of biotechnology.
Collaborations
Chapin has collaborated with notable professionals in his field, including Erik E Karrer and Madan M Paidhungat. These partnerships have further enriched his work and expanded the scope of his inventions.
Conclusion
Steven J Chapin's contributions to the field of immunology through his patents and collaborations highlight his role as a significant innovator. His work continues to influence advancements in medical treatments and therapies.